This study examines the associations between 12-step participation and outcomes over 7 years among 419 adolescent substance use patients with and without psychiatric comorbidities. Although level of participation decreased over time for both groups, comorbid adolescents participated in 12-step groups at comparable or higher levels across time points. Results from mixed-effects logistic regression models indicated that for both groups, 12-step participation was associated with both alcohol and drug abstinence at follow-ups, increasing the likelihood of either by at least 3 times. Findings highlight the potential benefits of 12-step participation in maintaining long-term recovery for adolescents with and without psychiatric disorders.
BuksteinO G, GlancyL J and KaminerY. 1992. Patterns of affective comorbidity in a clinical population of dually diagnosed adolescent substance abusers. J Am Acad Child Adolesc Psychiatry., 31: 1041–1045.
2.
Centers for Disease Control and Prevention. 1987. Human immunodeficiency virus infection in the United States: a review of current knowledge. MMWR., 36(SU06): 1–20.
3.
ChanY F, DennisM L and FunkR R. 2008. Prevalence and comorbidity of major internalizing and externalizing problems among adolescents and adults presenting to substance abuse treatment. J Subst Abuse Treat., 34: 14–24.
4.
ClarkD B and BuksteinO G. 1998. Psychopathology in adolescent alcohol abuse and dependence. Alcohol Health Res World., 22: 117–121. 126
5.
CromeI and BloorR. 2005. Substance misuse and psychiatric comorbidity in adolescents. Curr Opin Psychiatry., 18: 435–439.
6.
GriloC M, BeckerD F, WalkerM L, LevyK N, EdellW S and McGlashanT H. 1995. Psychiatric comorbidity in adolescent inpatients with substance use disorders. J Am Acad Child Adolesc Psychiatry., 34: 1085–1091.
7.
HserY I, GrellaC EHubbardR L. 2001. An evaluation of drug treatments for adolescents in 4 US cities. Arch Gen Psychiatry., 58: 689–695.
8.
KandelD B, JohnsonJ GBirdH R. 1999. Psychiatric comorbidity among adolescents with substance use disorders: findings from the MECA Study. J Am Acad Child Adolesc Psychiatry., 38: 693–699.
9.
KandelD B and YamaguchiK. 1985. Developmental patterns of the use of legal, illegal, and medically prescribed psychotropic drugs from adolescence to young adulthood. NIDA Res Monogr., 56: 193–235.
10.
LoeberR, GreenS M, LaheyB B, FrickP J and McBurnettK.2000. Findings on disruptive behavior disorders from the first decade of the Developmental Trends Study. Clin Child Fam Psychol Rev., 3: 37–60.
11.
MadianosM G, Madianou-GefouD and StefanisC N. 1993. Drug use and somatic illnesses with psychological component: a nation-wide survey among adolescents and adults in Greece. Psychother Psychosom., 60: 177–185.
12.
PrinsteinM J, BoergersJ and SpiritoA. 2001. Adolescents’ and their friends’ health-risk behavior: factors that alter or add to peer influence. J Pediatr Psychol., 26: 287–298.
13.
RiggsP D, BakerS, MikulichS K, YoungS E and CrowleyT J. 1995. Depression in substance-dependent delinquents. J Am Acad Child Adolesc Psychiatry., 34: 764–771.
14.
WhitmoreE A, MikulichS K, EhlersK M and CrowleyT J. 2000. One-year outcome of adolescent females referred for conduct disorder and substance abuse/dependence.. Drug Alcohol Depend, 59: 131–141.
15.
YamaguchiK. 1990. Drug use and its social covariates from the period of adolescence to young adulthood: some implications from longitudinal studies. Recent Dev Alcohol., 8: 125–143.
16.
RobertsR E, RobertsC R and XingY. 2007. Comorbidity of substance use disorders and other psychiatric disorders among adolescents: evidence from an epidemiologic survey. Drug Alcohol Depend., 88(Suppl 1): S4–S13.
17.
SterlingS and WeisnerC. 2005. Chemical dependency and psychiatric services for adolescents in private managed care: implications for outcomes. Alcohol Clin Exp Res., 25: 801–809.
18.
AaseD M, JasonL A and RobinsonW L. 2008. 12-Step participation among dually-diagnosed individuals: a review of individual and contextual factors. Clin Psychol Rev., 28: 1235–1248.
19.
BogenschutzM P, GeppertC M and GeorgeJ.2006. The role of twelve-step approaches in dual diagnosis treatment and recovery. Am J Addict., 15: 50–60.
20.
MoosR H and TimkoC. 2008. “Outcome research on 12-step and other self-help programs”. In The American Psychiatric Publishing Textbook of Substance Abuse Treatment. 4th ed, Edited by: GalanterM and KleberH D. 511–521. Arlington, VA: American Psychiatric Publishing.
21.
GrellaC E, JoshiV and HserY-I. 2004. Effects of comorbidity on treatment processes and outcomes among adolescents in Drug Treatment Programs. J Child Adolesc Subst Use., 13: 13–31.
22.
GordonN P. Characteristics of adult members in Kaiser Permanente's Northern California Region, as estimated from the 2008 Kaiser Permanente Health Survey. Kaiser Permanente Medical Care Program Division of Research. March 2010. Available at: http://www.dor.kaiser.org/external/mhs/documents/mhs08reg_e/. Accessed May 17, 2012
23.
SterlingS, KohnC S, LuY and WeisnerC. 2004. Pathways to chemical dependency treatment for adolescents in an HMO. J Psychoactive Drugs., 36: 439–453.
24.
ChiF W, SatreD D and WeisnerC. 2006. Chemical dependency patients with cooccurring psychiatric diagnoses: service patterns and 1-year outcomes. Alcohol Clin Exp Res., 30: 851–859.
25.
MertensJ R, FlisherA J, FlemingM F and WeisnerC M. 2007. Medical conditions of adolescents in alcohol and drug treatment: comparison with matched controls. J Adolesc Health., 40: 173–179.
26.
MertensJ R, LuY W, ParthasarathyS, MooreC and WeisnerC M. 2003. Medical and psychiatric conditions of alcohol and drug treatment patients in an HMO: comparison with matched controls. Arch Intern Med., 163: 2511–2517.
27.
DonovanD M and RosengrenD B. 1999. “Motivation for behavior change and treatment among substance abusers”. In Changing Addictive Behavior: Bridging Clinical and Public Health Strategies, Edited by: TuckerJ A, DonovanD M and MarlattG A. 126–159. New York: Guildford Press.
28.
MeyersK and CoyneT. 2007. Psychometric Information and National Utilization of the Comprehensive Adolescent Severity Inventory (CASI), Philadelphia: Philadelphia Safe and Sound.
29.
MeyersK, McLellanA T, JaegerJ L and PettinatiH M. 1995. The development of the Comprehensive Addiction Severity Index for Adolescents (CASI-A). An interview for assessing multiple problems of adolescents. J Subst Abuse Treat., 12: 181–193.
30.
WhitmoreE A, MikulichS K, ThompsonL L, RiggsP D, AaronsG A and CrowleyT J. 1997. Influences on adolescent substance dependence: conduct disorder, depression, attention deficit hyperactivity disorder, and gender. Drug Alcohol Depend., 47: 87–97.
31.
KellyJ F, MyersM G and BrownS A. 2002. Do adolescents affiliate with 12-step groups? A multivariate process model of effects. J Stud Alcohol., 63: 293–304.
32.
HumphreysK, KaskutasL A and WeisnerC. 1998. The Alcoholics Anonymous Affiliation Scale: development, reliability, and norms for diverse treated and untreated populations. Alcohol Clin Exp Res., 22: 974–978.
33.
ChiF W, KaskutasL A, SterlingS, CampbellC I and WeisnerC. 2009. Twelve-Step affiliation and 3-year substance use outcomes among adolescents: social support and religious service attendance as potential mediators. Addiction., 104: 927–939.
34.
De LeonG, MelnickG, KresselD and JainchillN. 1994. Circumstances, motivation, readiness, and suitability (the CMRS scales): predicting retention in therapeutic community treatment. Am J Drug Alcohol Abuse., 20: 495–515.
35.
CampbellC I, WeisnerC and SterlingS. 2006. Adolescents entering chemical dependency treatment in private managed care: ethnic differences in treatment initiation and retention. J Adolesc Health., 38: 343–350.
36.
WuN S, LuY, SterlingS and WeisnerC. 2004. Family environment factors and substance abuse severity in an HMO adolescent treatment population. Clin Pediatr., 43: 323–333.
37.
AchenbachT M. 1991. Manual for the Youth Self-Report and 1991 Profile, Burlington, VT: University of Vermont Department of Psychiatry.
38.
McConaughyS H and AchenbachT M. 2001. Manual for the Semistructured Clinical Interview for Children and Adolescents. 2nd ed, Burlington, VT: University of Vermont Research Center for Children, Youth, and Families.
39.
McConaughyS H, StangerC and AchenbachT M. 1992. Three-year course of behavioral/emotional problems in a national sample of 4- to 16-year-olds: I. Agreement among informants. J Am Acad Child Adolesc Psychiatry, 31: 932–940.
40.
RoweC L, LiddleH A, GreenbaumP E and HendersonC E. 2004. Impact of psychiatric comorbidity on treatment of adolescent drug abusers. J Subst Abuse Treat., 26: 129–140.
41.
RothmanK J. 1990. No adjustments are needed for multiple comparisons. Epidemiology, 1: 43–46.
42.
AndersonK G, RamoD E, SchulteM T, CumminsK and BrownS A. 2007. Substance use treatment outcomes for youth: integrating personal and environmental predictors. Drug Alcohol Depend., 88: 42–48.
43.
HsiehS, HoffmannN G and HollisterC D. 1998. The relationship between pre-, during-, post-treatment factors, and adolescent substance abuse behaviors. Addict Behav., 23: 477–488.
44.
SterlingS, ChiF W, CampbellC I and WeisnerC. 2009. Three-year chemical dependency and mental health treatment outcomes among adolescents: the role of continuing care. Alcohol Clin Exp Res., 33: 1417–1429.
45.
JordanL C, DavidsonW S, HermanS E and BootsMillerB J. 2002. Involvement in 12-step programs among persons with dual diagnoses. Psychiatr Serv., 53: 894–896.
46.
StraussnerS L and ByrneH. 2009. Alcoholics Anonymous: key research findings from 2002–2007. Alcohol Treat Q., 27: 349–367.
47.
NoordsyD L, SchwabB, FoxL and DrakeR E. 1996. The role of self-help programs in the rehabilitation of persons with severe mental illness and substance use disorders. Community Ment Health J., 32: 71–81. discussion 83–76
48.
KellyJ F and MyersM G. 2007. Adolescents’ participation in Alcoholics Anonymous and Narcotics Anonymous: review, implications and future directions. J Psychoactive Drugs., 39: 259–269.
49.
SussmanS. 2010. A review of Alcoholics Anonymous/Narcotics Anonymous programs for teens. Eval Health Prof, 33: 26–55.
